Pregabalin 99% CAS 148553-50-8
Kupu Whakataki:
| Ingoa matū: | Pregabalin |
| kupu taurite: | 3-(Aminomethyl)-5-methyl-hexanoic acid |
| Nama putea: | 148553-50-8 |
| Tātai rāpoi: | C8H17NO2 |
| Taumaha rāpoi: | 159.23 |
| Hanganga ngota: |
-Taupū Kounga Matua:
[Ahuatanga]]: ma te ahua o te karaihe ma.
[Ihirangi]]: ≥99.0%
[Te hurihanga motuhake]]: [α]D20+9.5~+11.5o(C=1,H2O)
-Whakamahia:
Ka whakamahia hei anticonvulsion, anti-epileptic drug.
-Whakaahuatanga
Ko te Pregabalin, he mea hokohoko i raro i te ingoa waitohu Lyrica i roto i etahi atu, he rongoa hei rongoa mo te epilepsy, te mamae neuropathic, te fibromyalgia, me te mate awangawanga whanui.Ko tana whakamahinga mo te mate pukupuku he rongoa taapiri mo te hopu i etahi waahanga me te kore ranei o te whaanui tuarua i roto i nga pakeke.Ko etahi o nga whakamahi i waho-tapanga o nga takawaenga pregabalin ko te mate o te waewae korekore, te aukati i te heke mai, te mate awangawanga hapori, me te tango waipiro.Ina whakamahia i mua i te pokanga karekau te ahua e pa ki te mamae i muri i te pokanga engari ka iti ake te whakamahinga o nga opioids.
Ko nga paanga o te taha noa ko: te moe, te rangirua, te raru o te mahara, te ngoikore o te whakahaere motuka, te waha maroke, te raru o te tirohanga, me te taumaha.Ko nga paanga taha kino pea ko te angioedema, te whakamahi kino i te tarukino, me te nui haere o te mate whakamomori.Ina tangohia nga kai takawaenga pregabalin ki nga pota teitei mo te wa roa, ka mate pea te mate mokemoke, engari mena ka tangohia i nga pota o mua ka iti te mate o te waranga.Kua whakarōpūtia hei riterite GABA.
I whakawhanakehia e Parke-Davis nga takawaenga pregabalin hei riiwhi mo te gabapentin ka kawea ki te maakete e Pfizer i muri i te rironga o te kamupene ki a Warner-Lambert.Karekau he putanga whanui e waatea ana i te United States tae noa ki te tau 2018. Kei Kanata me te United Kingdom tetahi momo whakaputanga.I te US te utu mo te 300-400 USD ia marama.Ko te Pregabalin he matū whakahaere i te Apiti V i raro i te Ture Mana Whakahaere o 1970 (CSA).
